GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Repurchase of Stock

AngioLab (XKRX:251280) Repurchase of Stock : ₩0.0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is AngioLab Repurchase of Stock?

AngioLab's Repurchase of Stock for the six months ended in Dec. 2023 was ₩0.0 Mil.

AngioLab's Repurchase of Stock for the trailing twelve months (TTM) ended in Dec. 2023 was ₩0.0 Mil.


AngioLab Repurchase of Stock Historical Data

The historical data trend for AngioLab's Repurchase of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab Repurchase of Stock Chart

AngioLab Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Repurchase of Stock
Get a 7-Day Free Trial - - - - -

AngioLab Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Repurchase of Stock Get a 7-Day Free Trial - - - - -

AngioLab Repurchase of Stock Calculation

A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of Stock represents the cash outflow to reacquire common stock during the period.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Repurchase of Stock for the trailing twelve months (TTM) ended in Dec. 2023 was ₩0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AngioLab Repurchase of Stock Related Terms

Thank you for viewing the detailed overview of AngioLab's Repurchase of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


AngioLab (XKRX:251280) Business Description

Traded in Other Exchanges
N/A
Address
65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN
AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines